443 related articles for article (PubMed ID: 34952583)
1. p53 signaling in cancer progression and therapy.
Marei HE; Althani A; Afifi N; Hasan A; Caceci T; Pozzoli G; Morrione A; Giordano A; Cenciarelli C
Cancer Cell Int; 2021 Dec; 21(1):703. PubMed ID: 34952583
[TBL] [Abstract][Full Text] [Related]
2. The p53 tumor suppressor gene and nuclear protein: basic science review and relevance in the management of bladder cancer.
Smith ND; Rubenstein JN; Eggener SE; Kozlowski JM
J Urol; 2003 Apr; 169(4):1219-28. PubMed ID: 12629332
[TBL] [Abstract][Full Text] [Related]
3. An overview of the functions of p53 and drugs acting either on wild- or mutant-type p53.
Huang Y; Jiao Z; Fu Y; Hou Y; Sun J; Hu F; Yu S; Gong K; Liu Y; Zhao G
Eur J Med Chem; 2024 Feb; 265():116121. PubMed ID: 38194777
[TBL] [Abstract][Full Text] [Related]
4. The Function of the Mutant p53-R175H in Cancer.
Chiang YT; Chien YC; Lin YH; Wu HH; Lee DF; Yu YL
Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439241
[TBL] [Abstract][Full Text] [Related]
5. Effects of TP53 mutational status on gene expression patterns across 10 human cancer types.
Parikh N; Hilsenbeck S; Creighton CJ; Dayaram T; Shuck R; Shinbrot E; Xi L; Gibbs RA; Wheeler DA; Donehower LA
J Pathol; 2014 Apr; 232(5):522-33. PubMed ID: 24374933
[TBL] [Abstract][Full Text] [Related]
6. Mutated p53 in HGSC-From a Common Mutation to a Target for Therapy.
Saleh A; Perets R
Cancers (Basel); 2021 Jul; 13(14):. PubMed ID: 34298679
[TBL] [Abstract][Full Text] [Related]
7. The Role of p53 Signaling in Colorectal Cancer.
Liebl MC; Hofmann TG
Cancers (Basel); 2021 Apr; 13(9):. PubMed ID: 33924934
[TBL] [Abstract][Full Text] [Related]
8. Targeting p53 pathways: mechanisms, structures, and advances in therapy.
Wang H; Guo M; Wei H; Chen Y
Signal Transduct Target Ther; 2023 Mar; 8(1):92. PubMed ID: 36859359
[TBL] [Abstract][Full Text] [Related]
9. Tumor suppressor p53 and its gain-of-function mutants in cancer.
Liu J; Zhang C; Feng Z
Acta Biochim Biophys Sin (Shanghai); 2014 Mar; 46(3):170-9. PubMed ID: 24374774
[TBL] [Abstract][Full Text] [Related]
10. Mutant p53 Protein and the Hippo Transducers YAP and TAZ: A Critical Oncogenic Node in Human Cancers.
Ferraiuolo M; Verduci L; Blandino G; Strano S
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28467351
[TBL] [Abstract][Full Text] [Related]
11. Recent findings on the role of wild-type and mutant p53 in cancer development and therapy.
Babamohamadi M; Babaei E; Ahmed Salih B; Babamohammadi M; Jalal Azeez H; Othman G
Front Mol Biosci; 2022; 9():903075. PubMed ID: 36225257
[TBL] [Abstract][Full Text] [Related]
12. Mutant p53 in Cancer Progression and Targeted Therapies.
Zhu G; Pan C; Bei JX; Li B; Liang C; Xu Y; Fu X
Front Oncol; 2020; 10():595187. PubMed ID: 33240819
[No Abstract] [Full Text] [Related]
13. A common gain of function of p53 cancer mutants in inducing genetic instability.
Liu DP; Song H; Xu Y
Oncogene; 2010 Feb; 29(7):949-56. PubMed ID: 19881536
[TBL] [Abstract][Full Text] [Related]
14. Mutant p53 accumulation in human breast cancer is not an intrinsic property or dependent on structural or functional disruption but is regulated by exogenous stress and receptor status.
Bouchalova P; Nenutil R; Muller P; Hrstka R; Appleyard MV; Murray K; Jordan LB; Purdie CA; Quinlan P; Thompson AM; Vojtesek B; Coates PJ
J Pathol; 2014 Jul; 233(3):238-46. PubMed ID: 24687952
[TBL] [Abstract][Full Text] [Related]
15. p53 gain-of-function cancer mutants induce genetic instability by inactivating ATM.
Song H; Hollstein M; Xu Y
Nat Cell Biol; 2007 May; 9(5):573-80. PubMed ID: 17417627
[TBL] [Abstract][Full Text] [Related]
16. Wild type- and mutant p53 proteins in mitochondrial dysfunction: emerging insights in cancer disease.
Blandino G; Valenti F; Sacconi A; Di Agostino S
Semin Cell Dev Biol; 2020 Feb; 98():105-117. PubMed ID: 31112799
[TBL] [Abstract][Full Text] [Related]
17. Complexes formed by mutant p53 and their roles in breast cancer.
Bellazzo A; Sicari D; Valentino E; Del Sal G; Collavin L
Breast Cancer (Dove Med Press); 2018; 10():101-112. PubMed ID: 29950894
[TBL] [Abstract][Full Text] [Related]
18. Binding of MAR-DNA elements by mutant p53: possible implications for its oncogenic functions.
Deppert W
J Cell Biochem; 1996 Aug; 62(2):172-80. PubMed ID: 8844397
[TBL] [Abstract][Full Text] [Related]
19. Interference with the p53 family network contributes to the gain of oncogenic function of mutant p53 in hepatocellular carcinoma.
Schilling T; Kairat A; Melino G; Krammer PH; Stremmel W; Oren M; Müller M
Biochem Biophys Res Commun; 2010 Apr; 394(3):817-23. PubMed ID: 20233581
[TBL] [Abstract][Full Text] [Related]
20. Role of p53 in regulation of hematopoiesis in health and disease.
Barajas S; Cai W; Liu Y
Curr Opin Hematol; 2022 Jul; 29(4):194-200. PubMed ID: 35787548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]